Afinitor 10 mg (Everolimus TABLET) 10 MG

AFINITOR 10 MG tablets contain everolimus, a medication used to manage certain conditions. This oral tablet is manufactured by Novartis Pharmaceuticals Canada Inc.

Strength

10 MG

Pack Size

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AFINITOR 10 MG tablets are typically used in the management of specific medical conditions. Everolimus, the active ingredient, is often prescribed for its therapeutic effects in targeted treatments. Patients may wonder, 'What is AFINITOR used for?' This medication is generally utilized in scenarios where precise control of cellular processes is necessary.

Side Effects

Common effects of AFINITOR 10 MG tablets may include mild to moderate side effects such as fatigue, nausea, or skin reactions. These effects can vary among individuals and are not exhaustive. It's important to consult healthcare providers for personalized information.

Precautions & Warnings

Handling AFINITOR 10 MG tablets requires adherence to prescribed guidelines. Store the medication as directed and follow safety protocols to ensure proper usage. Always consult healthcare professionals for specific precautions related to your condition.

Avoid Interactions

AFINITOR 10 MG tablets may interact with certain substances, including other medications, supplements, or specific foods. It's advisable to inform healthcare providers about all current treatments to avoid potential interactions. Alcohol and certain inhibitors may also affect the medication's efficacy.

Frequently Asked Questions

AFINITOR 10 MG tablets are used in the management of specific medical conditions, often involving targeted cellular processes.

AFINITOR 10 MG tablets are taken orally, typically as directed by a healthcare provider. Follow the prescribed dosage and administration guidelines.

Common side effects of AFINITOR 10 MG tablets may include fatigue, nausea, or skin reactions. Individual experiences can vary.

It's advisable to consult your healthcare provider about alcohol consumption while taking AFINITOR 10 MG tablets, as it may affect the medication's efficacy.

Store AFINITOR 10 MG tablets as directed by the manufacturer, typically in a cool, dry place away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.